טוען...
Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma is a disease of great concern. Surgery is the treatment of choice, but there is still a high recurrence rate after resection. OBJECTIVES: To determine the benefits and harms of neoadjuvant and adjuvant therapies compared to surgery alone or surgery and placebo/su...
שמור ב:
| הוצא לאור ב: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2009
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7096780/ https://ncbi.nlm.nih.gov/pubmed/19160192 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001199.pub2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|